pyridoxal phosphate has been researched along with Cerebral Ischemia in 6 studies
Pyridoxal Phosphate: This is the active form of VITAMIN B 6 serving as a coenzyme for synthesis of amino acids, neurotransmitters (serotonin, norepinephrine), sphingolipids, aminolevulinic acid. During transamination of amino acids, pyridoxal phosphate is transiently converted into pyridoxamine phosphate (PYRIDOXAMINE).
pyridoxal 5'-phosphate : The monophosphate ester obtained by condensation of phosphoric acid with the primary hydroxy group of pyridoxal.
Excerpt | Relevance | Reference |
---|---|---|
"Epidemiological studies have described an association between low vitamin B6 (measured as pyridoxal 5'-phosphate [PLP]) and ischemic stroke, independent of homocysteine (tHcy)." | 7.72 | Inflammation, homocysteine, and vitamin B6 status after ischemic stroke. ( Atassi, N; Barron, M; Furie, KL; Kelly, PJ; Kistler, JP; Lee, H; Mandell, R; Shih, VE; Silveira, S, 2004) |
"Epidemiological studies have described an association between low vitamin B6 (measured as pyridoxal 5'-phosphate [PLP]) and ischemic stroke, independent of homocysteine (tHcy)." | 3.72 | Inflammation, homocysteine, and vitamin B6 status after ischemic stroke. ( Atassi, N; Barron, M; Furie, KL; Kelly, PJ; Kistler, JP; Lee, H; Mandell, R; Shih, VE; Silveira, S, 2004) |
" In the present project, the authors have studied whether MC-1, an analog of PLP, alone or in combination with the thrombolytic agent tissue plasminogen activator (tPA), can protect the brains of rats injured by ischemia." | 1.33 | Role of MC-1 alone and in combination with tissue plasminogen activator in focal ischemic brain injury in rats. ( Noor, R; Shuaib, A; Wang, CX; Yang, T, 2005) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 6 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Zhang, W | 1 |
Yao, J | 1 |
Pham, V | 1 |
Whitney, T | 1 |
Froese, D | 1 |
Friesen, A | 1 |
Stang, L | 1 |
Xu, C | 1 |
Shuaib, A | 2 |
Diakur, JM | 1 |
Haque, W | 1 |
Kelly, PJ | 1 |
Kistler, JP | 1 |
Shih, VE | 1 |
Mandell, R | 1 |
Atassi, N | 1 |
Barron, M | 1 |
Lee, H | 1 |
Silveira, S | 1 |
Furie, KL | 1 |
Wang, CX | 1 |
Yang, T | 1 |
Noor, R | 1 |
Lämmer, A | 1 |
Günther, A | 1 |
Beck, A | 1 |
Krügel, U | 1 |
Kittner, H | 1 |
Schneider, D | 1 |
Illes, P | 1 |
Franke, H | 1 |
Hwang, IK | 1 |
Yoo, KY | 1 |
Kim, DH | 1 |
Lee, BH | 1 |
Kwon, YG | 1 |
Won, MH | 1 |
Yamashima, T | 1 |
Zhao, L | 1 |
Wang, XD | 1 |
Tsukada, T | 1 |
Tonchev, AB | 1 |
6 other studies available for pyridoxal phosphate and Cerebral Ischemia
Article | Year |
---|---|
Pyridoxine as a template for the design of antiplatelet agents.
Topics: Animals; Brain Ischemia; Disease Models, Animal; Humans; In Vitro Techniques; Intracranial Thrombosi | 2004 |
Inflammation, homocysteine, and vitamin B6 status after ischemic stroke.
Topics: Aged; Brain Ischemia; C-Reactive Protein; Comorbidity; Female; Homocysteine; Humans; Inflammation; M | 2004 |
Role of MC-1 alone and in combination with tissue plasminogen activator in focal ischemic brain injury in rats.
Topics: Animals; Blood Pressure; Brain Ischemia; Cerebrovascular Circulation; Disease Models, Animal; Dose-R | 2005 |
Neuroprotective effects of the P2 receptor antagonist PPADS on focal cerebral ischaemia-induced injury in rats.
Topics: Animals; Brain; Brain Ischemia; Immunohistochemistry; Injections, Intraventricular; Male; Neuroprote | 2006 |
Time course of changes in pyridoxal 5'-phosphate (vitamin B6 active form) and its neuroprotection in experimental ischemic damage.
Topics: 4-Aminobutyrate Transaminase; Aldehyde Oxidoreductases; Animals; Astrocytes; Brain Infarction; Brain | 2007 |
Neuroprotective effects of pyridoxal phosphate and pyridoxal against ischemia in monkeys.
Topics: Animals; Brain Ischemia; Cathepsin B; Cathepsin L; Cathepsins; Cell Death; Cysteine Endopeptidases; | 2001 |